Inhibitory effects of eight green tea catechins on cytochrome P450 1A2, 2C9, 2D6, and 3A4 activities

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 19, Issue 2, 2016, Pages 188-197

  Satoh, Takashi ^a   Fujisawa, Haruka ^a   Nakamura, Ami ^a   Takahashi, Natsuko ^a   Watanabe, Kazuhiro ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHIN; CATECHIN 3 O GALLATE; CATECHOL DERIVATIVE; CYTOCHROME P450 1A2; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; EPICATECHIN; EPICATECHIN 3 O GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALLOCATECHIN; GALLOCATECHIN 3 O GALLATE; UNCLASSIFIED DRUG; CYTOCHROME P450; CYTOCHROME P450 INHIBITOR; TEA;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; ANALOGS AND DERIVATIVES; CHEMISTRY; METABOLISM; TEA;

CATECHIN; CYTOCHROME P-450 ENZYME INHIBITORS; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; TEA;

EID: 84973897659     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3ms5c     Document Type: Article

References (35)

1. Cho HJ, Yoon IS. Pharmacokinetic interactions of herbs with cytochrome P450 and P-glycoprotein. Evid Based Complement Alternat Med, 2015; 736431. doi: 10.1155/2015/736431.
2. Cabinet Office, Government of Japan. Survey regarding use of "health food" in consumers (questionnaire survey). http://www.cao.go.jp/consumer/iinkaikouhyou/2012/houkoku/201205_report.html, 2012; cited on February, 04, 2016.
3. Satoh T, Fujita K, Munakata M, Itoh S, Nakamura K, Kamataki T, Itoh S, Yoshizawa I. Studies on the interactions between drugs and estrogen: Analytical method for prediction system of gynecomastia induced by drugs on the inhibitory metabolism of estradiol using Escherichia coli coexpressing human CYP3A4 with human NADPH-cytochrome P450 reductase. Anal Biochem, 2000; 286:179-186.
4. Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther, 2013; 138:103-141. doi: 10.1016/j.pharmthera.2012.12.007.
5. Nguyen S, Huang H, Foster BC, Tam TW, Xing T, Smith ML, Arnason JT, Akhtar H. Antimicrobial and P450 inhibitory properties of common functional foods. J Pharm Pharm Sci, 2014; 17:254-265. doi: http://dx.doi.org/10.18433/J3P599.
6. Liu R, Tam TW, Mao J, Saleem A, Krantis A, Arnason JT, Foster BC. The effect of natural health products and traditional medicines on the activity of human hepatic microsomal-mediated metabolism of oseltamivir. J Pharm Pharm Sci, 2010; 13:43-55. doi: http://dx.doi.org/10.18433/J3ZP42.
7. Tam TW, Akhtar H, Arnason JT, Cvijovic K, Boon H, Cameron DW, Drouin CE, Jaeger W, Tsuyuki RT, Vohra S, Foster BC. Inhibition of human cytochrome P450 metabolism by blended herbal products and vitamins. J Pharm Pharm Sci, 2011; 14:1-16. doi: http://dx.doi.org/10.18433/J3N30W.
8. Tam TW, Liu R, Saleem A, Arnason JT, Krantis A, Foster BC. Cytochrome P450 3A4 and 2D6-mediated metabolism of leisure and medicinal teas. J Pharm Pharm Sci, 2014; 17:294-301. doi: http://dx.doi.org/10.18433/J3902H.
9. de Lima Toccafondo Vieira M, Huang SM. Botanical-drug interactions: a scientific perspective. Planta Med, 2012; 78:1400-1415. doi: 10.1055/s-0032-1315145.
10. Hermann R, von Richter O. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Planta Med, 2012; 78:1458-1477. doi: 10.1055/s-0032-1315117.
11. Ruschitzka F, Meier PJ, Turina M, Lüscher TF, Noll G. Acute heart transplant rejection due to St John’s wort. Lancet, 2000; 355:548–549.
12. Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Sparreboom A. Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst, 2002; 94:1247-1249.
13. Tsuchida Y, Itakura H, Nakamura H. Reduction of body fat in human by long-term ingestion of catechins. Prog Med, 2002; 22:2189-2203.
14. Kozuma K, Chikama A, Hoshino E, Kataoka K, Mori K, Hase T, Katsuragi Y, Tokimitsu I, Nakamura N. Effect of intake of a beverage containing 540 mg catechins on the body composition of obese women and men. Prog Med, 2005; 25:1945-1957.
15. Ota N, Soga S, Shimotoyodome A, Haramizu S, Inaba M, Murase T, Tokimitsu I. Effects of combination of regular exercise and tea catechins intake on energy expenditure in humans. J Health Sci, 2005; 51:233-236.
16. Yamada K, Sato-Mito N, Nagata J, Umegaki K. Health claim evidence requirements in Japan. J Nutr, 2008; 138:1192S-1198S.
17. Kokubo Y, Iso H, Saito I, Yamagishi K, Yatsuya H, Ishihara J, Inoue M, Tsugame S. The impact of green tea and coffee consumption on the reduced risk of stroke incidence in Japanese population. The Japan public health center-based study cohort. Stroke, 2013; 44:1369-1374. doi: 10.1161/STROKEAHA.111.677500.
18. Sarma DN, Barrett ML, Chavez ML, Gardiner P, Ko L, Mahady GB, Marles RJ, Pellicore LS, Giancaspro GI, Dog TL. Safety of green tea extracts. A systemic review by the US pharmacopeia. Drug Safety, 2008; 31:469-484.
19. Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, Santuccio C, Mastrangelo S. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol, 2009; 65:331-341. doi: 10.1007/s00228-008-0610-7.
20. Ikeda I, Kobayashi M, Hamada T, Tsuda K, Goto H, Imaizumi K, Nozawa A, Sugimoto A, Kakuda T. Heat-epimerized tea catechins rich in gallocatechin gallate and gatechin gallate are more effective to inhibit cholesterol absorption than tea catechins rich in epigallocatechin gallate and epicatechin gallate. J Agric Food Chem, 2003; 51: 7303-7307.
21. Seto R, Nakamura H, Nanjo F, Hara Y. Preparation of epimers of tea catechins by heat treatment. Biosci Biotech Biochem, 1997; 61: 1434-1439.
22. Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician, 2007; 76:391-396.
23. Kozakai K, Yamada Y, Oshikata M, Kawase T, Suzuki E, Haramaki Y, Taniguchi H. Reliable high-throughput method for inhibition assay of 8 cytochrome P450 isoforms using cocktail of probe substrates and stable isotope-labeled internal standards. Drug Metab Pharmacokinet, 2012; 27:520-529.
24. US FDA. Drug development and drug interactions: table of substrates, inhibitors and inducers. U.S. Food and Drug Administration. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabe ling/ucm093664.htm; cited on May, 12, 2016.
25. Muto S, Fujita K, Yamazaki Y, Kamataki T. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mut Res, 2001; 479:197-206.
26. Misaka S, Kawabe K, Onoue S, Werba LP, Girou M., Tamaki S, Kan T, Kimura J, Watanabe H, Yamada S. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A4 activities in human liver and intestinal microsomes. Drug Metab Pharmacokinet, 2013; 28:244-249.
27. Babich H, Zuckerbraun HL, Weinerman SM. In vitro cytotoxicity of (−)-catechin gallate, a minor polyphenol in green tea. Toxicol Lett, 2007; 171:171-180.
28. Kürbitz C, Heise D, Redmer T, Goumas F, Arlt A, Lemke J, Rimbach G, Kalthoff H, Trauzold A. Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells. Cancer Sci, 2011; 102:728-734. doi: 10.1111/j.1349-7006.2011.01870.x.
29. Srtobel P, Allard C, Perez-Acle T, Calderon R, Aldunate R, Leighton F. Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem J, 2005; 386:471-478.
30. Imai K, Suga K, Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med, 1997; 26:769-775.
31. Nakagawa K, Okuda S, Miyazawa T. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem, 1997; 61:1981-1985.
32. Chow H-HS, Hakin IA, Vining DR, Crowell JA, Ranger-Moore J, Chew WM, Celaya CA, Rodney SR, Hara Y, Alberts DS. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals. Clin Cancer Res, 2005; 11:4627-4633.
33. Chow H-HS, Cai Y, Alberts DS, Hakin I, Dorr R, Shahi F, Crowell JA, Yang CS, Hara Y. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev, 2001; 10:53-58.
34. Lee M-J, Maliakal P, Chen L, Meng X, Bondoc FY, Prabhu S, Lambert G, Mohr S, Yang CS. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev, 2002; 11:1025-1032.
35. Chow H-HS, Hakin IA, Vining DR, Crowell JA, Cordova CA, Chew WM, Xu MJ, Hus CH, Ranger-Moore J, Alberts DS. Effects of repeated green tea catechin administration on human cytochrome P450 activity. Cancer Epidemiol Biomarkers Prev, 2006; 15:2473-2476.